CD2BP2

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, CD2BP2 mutation is significantly associated with the RNA expression of many other genes, with 605 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible CD2BP2-associated genes across cancer lineages are MIR4504, RNU6-921P, and ATP5F1EP1. Each is linked with CD2BP2 in more than 1 cancer types. Because this analysis shows association rather than direction, both CD2BP2-to-partner and partner-to-CD2BP2 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, MIR4504 grouped by CD2BP2-low versus CD2BP2-high in BLCA.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (CD2BP2→partner) and Y-score (partner→CD2BP2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLCAMIR4504 →+0.484+5.320<.001.00132
COADRNU6-921P →+0.541+4.516<.001.00932
UCECATP5F1EP1 →+0.220+2.255.008.00932
SKCMSNORD111B →+0.381+3.979<.001.00332
BLCARNU6-456P →+0.330+6.307<.001<.00132
UCECTIMM8B →+0.430+3.212.009.00931
Each partner links to its Q-omics profile. Showing the 6 strongest of 605 associations by consensus.

MIR4504 by CD2BP2 expression — BLCA

Box plot of MIR4504 in CD2BP2-low vs CD2BP2-high samples in BLCA.

Explore this box plot interactively →

Exploration